Printer Friendly

IMRE ANNOUNCES YEAR END RESULTS

 IMRE ANNOUNCES YEAR END RESULTS
 SEATTLE, March 9 /PRNewswire/ -- IMRE Corporation (NASDAQ: IMRE)


today announced revenues of $2.712 million for the year ended Dec. 31, 1991, compared with $1.859 million in 1990. The net loss for the year was $1.453 million, or 14 cents per share, compared with $1.632 million, or 26 cents per share, in 1990.
 For the three months ended Dec. 31, 1991, the company reported revenues of $864,012 versus $314,524 in 1990. The loss was $199,618, or 1 percent per share, compared to $592,703, or 8 cents per share, for the same period in the previous year.
 The increase in revenues of $549,488 or 174.7 percent for the three months ended Dec. 31, 1991 compared to 1990 is due to an increase in marketing and sales personnel to 13 in 1991 from four in 1990, and an increase in available funds to support their efforts. These funds were made available through a public offering of 1,850,000 units in September 1991, which raised $11,100,000. The net loss for the quarter ended Dec. 31, 1991, decreased $393,085 or 66.3 percent from the same period in the previous year due primarily to an increase in revenues during the quarter.
 IMRE Corporation is a medical products company that is the leader in the field of immunoadsorption. The company's first product, the PROSORBA(R) column, has been approved by the Food and Drug Administration for treatment of idiopathic thrombocytopenic purpura, an immune-related bleeding disorder. The company is currently conducting clinical trials in rheumatoid arthritis, other autoimmune diseases and certain cancers.
 IMRE CORPORATION
 Consolidated Financial Data
 (In thousands, except per share data)
 Period ended Three Months Year
 Dec. 31 1991 1990 1991 1990
 Sales $ 864 $ 315 $ 2,712 $ 1,859
 Interest income 119 34 193 36
 Total revenues 983 349 2,905 1,895
 Expenses 1,183 946 4,359 3,531
 Net loss from operations (200) (597) (1,454) (1,636)
 Minority share of loss -- 4 1 4
 Net loss $ (200) $ (593) $(1,453) $(1,632)
 Net loss per share $(.01) $(.08) $(.14) $(.26)
 Weighted average shares
 outstanding 14,014 7,209 10,160 6,182
 -0- 3/9/92
 /CONTACT: Lois Yoshida of IMRE, 206-298-9400/
 (IMRE) CO: IMRE Corporation ST: Washington IN: MTC SU: ERN


GK-TS -- NY017 -- 6263 03/09/92 09:41 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 9, 1992
Words:399
Previous Article:UNI-MARTS, INC. DECLARES QUARTERLY CASH DIVIDEND
Next Article:NEW BRITAIN'S 'FAFNIR BEARING PLANT,' A.K.A. BOOTH STREET BUILDING, SET FOR MARCH AUCTION
Topics:


Related Articles
IMRE CORPORATION ANNOUNCES THIRD QUARTER RESULTS
IMRE CORPORATION ANNOUNCES YEAR-END RESULTS
IMRE CORPORATION ANNOUNCES FIRST QUARTER RESULTS
IMRE CORP. ANNOUNCES THIRD QUARTER RESULTS; QUARTERLY SALES OF PROSORBA COLUMN REACH $2,000,000 FOR THE FIRST TIME
IMRE CORP. ANNOUNCES FIRST QUARTER RESULTS
IMRE CORPORATION ANNOUNCES THIRD QUARTER RESULTS
IMRE CORPORATION ANNOUNCES YEAR-END RESULTS
IMRE CORPORATION ANNOUNCES SECOND QUARTER RESULTS
IMRE CORPORATION ANNOUNCES THIRD QUARTER RESULTS
IMRE CORPORATION ANNOUNCES YEAR END RESULTS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters